FDA Approves First Automated Insulin Delivery Device for Type 1 Diabetics: September 28, 2016. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm522974.htm (accessed March23, 2017).
2.
KropffJ, DeVriesJH: Continuous glucose monitoring, future products, and update on worldwide artificial pancreas projects. Diabetes Technol Ther, 2016; 18Suppl 2:S253–S263.
3.
ForlenzaGP, BuckinghamB, MaahsDM: Progress in diabetes technology: developments in insulin pumps, continuous glucose monitors, and progress towards the artificial pancreas. J Pediatr, 2016; 169:13–20.
4.
ThabitH, HovorkaR: Coming of age: the artificial pancreas for type 1 diabetes. Diabetologia, 2016; 59:1795–1805.
5.
StreisandR, MonaghanM: Young children with type 1 diabetes: challenges, research, and future directions. Curr Diab Rep, 2014; 14:520.
6.
PowersSW, ByarsKC, MitchellMJ, et al.: Parent report of mealtime behavior and parenting stress in young children with type 1 diabetes and in healthy control subjects. Diabetes Care, 2002; 25:313–318.
7.
GandrudLM, XingD, KollmanC, et al.: The Medtronic Minimed Gold continuous glucose monitoring system: an effective means to discover hypo- and hyperglycemia in children under 7 years of age. Diabetes Technol Ther, 2007; 9:307–316.
8.
Sullivan-BolyaiS, DeatrickJ, GruppusoP, et al.: Mothers' experiences raising young children with type 1 diabetes. J Spec Pediatr Nurs, 2002; 7:93–103.
9.
HattonDL, CanamC, ThorneS, HughesAM: Parents' perceptions of caring for an infant or toddler with diabetes. J Adv Nurs, 1995; 22:569–577.
10.
PattonSR, DolanLM, SmithLB, et al.: Pediatric parenting stress and its relation to depressive symptoms and fear of hypoglycemia in parents of young children with type 1 diabetes mellitus. J Clin Psychol Med Settings, 2011; 18:345–352.
11.
BeckRW, TamborlaneWV, BergenstalRM, et al.: The T1D Exchange clinic registry. J Clin Endocrinol Metab, 2012; 97:4383–4389.
12.
MillerKM, FosterNC, BeckRW, et al.: Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care, 2015; 38:971–978.
13.
MaahsDM, HermannJM, DuBoseSN, et al.: Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries. Diabetologia, 2014; 57:1578–1585.
14.
ViaeneAS, Van DaeleT, BleysD, et al.: Fear of hypoglycemia, parenting stress, and metabolic control for children with type 1 diabetes and their parents. J Clin Psychol Med Settings, 2017; 24:74–81.
15.
TronconeA, BonfantiR, IafuscoD, et al.: Evaluating the experience of children with type 1 diabetes and their parents taking part in an artificial pancreas clinical trial over multiple days in a diabetes camp setting. Diabetes Care, 2016; 39:2158–2164.
16.
Muller-GodeffroyE, TreichelS, WagnerVM; German Working Group for Paediatric Pump Thearpy: Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus—a large-scale multicentre pilot study. Diabet Med, 2009; 26:493–501.
17.
AlsalehFM, SmithFJ, TaylorKM: Experiences of children/young people and their parents, using insulin pump therapy for the management of type 1 diabetes: qualitative review. J Clin Pharm Ther, 2012; 37:140–147.
18.
TsalikianE, FoxL, WeinzimerS, et al.: Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes. Pediatr Diabetes, 2012; 13:301–307.
19.
Del FaveroS, BoscariF, MessoriM, et al.: Randomized summer camp crossover trial in 5- to 9-year-old children: outpatient wearable artificial pancreas is feasible and safe. Diabetes Care, 2016; 39:1180–1185.
20.
DauberA, CorciaL, SaferJ, et al.: Closed-loop insulin therapy improves glycemic control in children aged <7 years: a randomized controlled trial. Diabetes Care, 2013; 36:222–227.
21.
RussellSJ, HillardMA, BalliroC, et al.: Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Lancet Diabetes Endocrinol, 2016; 4:233–243.
22.
TauschmannM, AllenJM, WilinskaME, et al.: Home use of day-and-night hybrid closed-loop insulin delivery in suboptimally controlled adolescents with type 1 diabetes: a 3-week, free-living, randomized crossover trial. Diabetes Care, 2016; 39:2019–2025.
23.
LyTT, BretonMD, Keith-HynesP, et al.: Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Care, 2014; 37:2310–2316.
24.
AndersonSM, RaghinaruD, PinskerJE, et al.: Multinational home use of closed-loop control is safe and effective. Diabetes Care, 2016; 39:1143–1150.
25.
ThabitH, HovorkaR: Coming of age: the artificial pancreas for type 1 diabetes. Diabetologia, 2016; 59:1795–1805.
26.
Writing Group for the SEARCH for Diabetes in Youth Study Group; DabeleaD, BellRA, et al.: Incidence of diabetes in youth in the United States. JAMA, 2007; 297:2716–2724.
27.
DeBoerMBM, BretonMD, WakemanC, et al.: Performance of an artificial pancreas system for young children with type 1 diabetes. Diabetes Technol Ther, 2017; 19:293–298.
28.
FrohnertBI, AlonsoGT: Challenges in delivering smaller doses of insulin. Diabetes Technol Ther, 2015; 17:597–599.
29.
MianowskaB, FendlerW, TomasikB, et al.: Effect of insulin dilution on lowering glycemic variability in pump-treated young children with inadequately controlled type 1 diabetes. Diabetes Technol Ther, 2015; 17:605–610.
30.
ElleriD, AllenJM, TauschmannM, et al.: Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3–6 years: comparison between diluted and standard insulin strength. BMJ Open Diabetes Res Care, 2014; 2:e000040.
31.
ZanfardinoA, IafuscoD, PiscopoA, et al.: Continuous subcutaneous insulin infusion in preschool children: butt or tummy, which is the best infusion set site?. Diabetes Technol Ther, 2014; 16:563–566.
32.
MesserLH, CalhounP, BuckinghamB, et al.: In-home nighttime predictive low glucose suspend experience in children and adults with type 1 diabetes. Pediatr Diabetes, 2016; doi: 10.1111/pedi.12395:1-8.
33.
BinderE, LangeO, EdlingerM, et al.: Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes, 2015; 123:260–264.
34.
WheelerBJ, HeelsK, DonaghueKC, et al.: Insulin pump-associated adverse events in children and adolescents—a prospective study. Diabetes Technol Ther, 2014; 16:558–562.
35.
WardWK, HeinrichG, BreenM, et al.: An amperometric glucose sensor integrated into an insulin delivery cannula: in vitro and in vivo evaluation. Diabetes Technol Ther, 2017; 19:226–236.
